ROIV insider transactions
Roivant Sciences Ltd. (ROIV) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for ROIV
- CEO Gline Matthew covered exercise/tax liability with 76,171 shares, decreasing direct ownership by 0.46% to 16,659,945 units (SEC Form 4) (for withholding tax)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- Director Fitzgerald Meghan exercised 10,000 shares at a strike of $8.80 and sold $349,000 worth of shares (10,000 units at $34.90) (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- President and Vant Chair Torti Frank covered exercise/tax liability with 40,310 shares, decreasing direct ownership by 0.30% to 13,536,202 units (SEC Form 4) to cover withholding tax4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- President & CIO Sukhatme Mayukh covered exercise/tax liability with 46,878 shares, decreasing direct ownership by 0.25% to 18,630,739 units (SEC Form 4) to satisfy tax liability4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- Director Epperly Melissa B, sold $610,252 worth of shares (17,750 units at $34.38) and exercised 17,750 shares at a strike of $4.46 (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- Director Manchester Keith S sold $56,444,076 worth of shares (1,638,163 units at $34.46), decreasing direct ownership by 10% to 1,748,403 units (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- Director Gold Daniel Allen sold $49,354,076 worth of shares (1,438,163 units at $34.32) (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- Director by Deputization Qvt Financial Lp sold $49,354,076 worth of shares (1,438,163 units at $34.32) (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- President & CIO Sukhatme Mayukh exercised 1,000,000 shares at a strike of $3.85 and sold $34,105,000 worth of shares (1,000,000 units at $34.10) (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- President & Immunovant CEO Venker Eric exercised 200,000 shares at a strike of $3.85 and sold $6,631,268 worth of shares (200,000 units at $33.16) (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- CFO Pulik Richard covered exercise/tax liability with 2,129 shares, decreasing direct ownership by 0.76% to 276,420 units (SEC Form 4) to satisfy tax liability4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- Chief Accounting Officer Humes Jennifer covered exercise/tax liability with 3,582 shares, decreasing direct ownership by 3% to 109,782 units (SEC Form 4) (for withholding tax)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- President & Immunovant CEO Venker Eric exercised 200,000 shares at a strike of $3.85, sold $6,054,000 worth of shares (200,000 units at $30.27) and covered exercise/tax liability with 34,483 shares, decreasing direct ownership by 2% to 1,613,063 units (SEC Form 4) (withholding obligation)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- CFO Pulik Richard covered exercise/tax liability with 18,962 shares, decreasing direct ownership by 6% to 278,549 units (SEC Form 4) to satisfy withholding tax4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- SEC Form 4 filed by Venker Eric4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- SEC Form 4 filed by Pulik Richard4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- SEC Form 4 filed by Humes Jennifer4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- SEC Form 4 filed by Oren Ilan4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- SEC Form 4 filed by Epperly Melissa B,4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- SEC Form 4 filed by Momtazee James C4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- SEC Form 4 filed by Gline Matthew4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- SEC Form 4 filed by Humes Jennifer4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- SEC Form 4 filed by Torti Frank4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- SEC Form 4 filed by Gline Matthew4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- SEC Form 4 filed by Sukhatme Mayukh4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- SEC Form 4 filed by Fitzgerald Meghan4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- SEC Form 4 filed by Pulik Richard4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- SEC Form 4 filed by Humes Jennifer4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- SEC Form 4 filed by Venker Eric4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- SEC Form 4 filed by Epperly Melissa B,4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- CFO Pulik Richard covered exercise/tax liability with 1,000 shares, decreasing direct ownership by 0.42% to 238,413 units (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- President & Immunovant CEO Venker Eric covered exercise/tax liability with 7,051 shares, decreasing direct ownership by 0.43% to 1,647,546 units (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- President and Vant Chair Torti Frank exercised 3,000,000 shares at a strike of $3.85 and sold $82,039,460 worth of shares (3,000,000 units at $27.35) (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- President & Immunovant CEO Venker Eric exercised 200,000 shares at a strike of $3.85 and sold $5,298,000 worth of shares (200,000 units at $26.49) (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- Director Manchester Keith S sold $32,658,518 worth of shares (1,225,784 units at $26.64) (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- Director Gold Daniel Allen sold $32,658,518 worth of shares (1,225,784 units at $26.64) (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- Director by Deputization Qvt Financial Lp sold $32,658,518 worth of shares (1,225,784 units at $26.64) (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- President & CIO Sukhatme Mayukh exercised 651,558 shares at a strike of $12.68, sold $8,985,003 worth of shares (339,441 units at $26.47) and disposed of $8,261,737 worth of shares (312,117 units at $26.47) (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- Director Momtazee James C was granted 609 shares and covered exercise/tax liability with 122 shares, increasing direct ownership by 0.45% to 109,030 units (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- Director Epperly Melissa B, covered exercise/tax liability with 54 shares and was granted 815 shares, increasing direct ownership by 1% to 57,665 units (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- Director Oren Ilan was granted 1,164 shares and covered exercise/tax liability with 124 shares, increasing direct ownership by 0.88% to 119,428 units (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- President & Immunovant CEO Venker Eric sold $4,384,000 worth of shares (200,000 units at $21.92) and exercised 200,000 shares at a strike of $3.85 (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- President & CIO Sukhatme Mayukh disposed of $40,553,632 worth of shares (1,867,367 units at $21.72), exercised 3,198,235 shares at a strike of $12.68 and sold $28,902,500 worth of shares (1,330,868 units at $21.72) (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- President and Vant Chair Torti Frank was granted 175,380 shares, disposed of $1,458,101 worth of shares (64,891 units at $22.47) and gifted 110,489 shares (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- President & Immunovant CEO Venker Eric exercised 431,689 shares at a strike of $3.85 and sold $6,179,750 worth of shares (275,000 units at $22.47), increasing direct ownership by 10% to 1,654,597 units (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- CFO Pulik Richard exercised 260,000 shares at a strike of $3.85 and sold $9,122,307 worth of shares (406,731 units at $22.43), decreasing direct ownership by 38% to 239,413 units (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- CFO Pulik Richard covered exercise/tax liability with 2,129 shares, decreasing direct ownership by 0.55% to 386,144 units (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- President & CIO Sukhatme Mayukh exercised 59,513 shares at a strike of $12.68, sold $619,528 worth of shares (26,831 units at $23.09) and disposed of $754,627 worth of shares (32,682 units at $23.09) (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- Director Gold Daniel Allen sold $39,065,213 worth of shares (1,694,614 units at $23.05) (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- Director Manchester Keith S sold $39,065,213 worth of shares (1,694,614 units at $23.05) (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- Director by Deputization Qvt Financial Lp sold $39,065,213 worth of shares (1,694,614 units at $23.05) (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- CEO Gline Matthew exercised 3,870,659 shares at a strike of $12.16, sold $37,723,200 worth of shares (1,740,000 units at $21.68) and disposed of $46,192,687 worth of shares (2,130,659 units at $21.68) (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- Large owner Ramaswamy Vivek exercised 7,374,868 shares at a strike of $12.68, sold $67,942,352 worth of shares (3,103,745 units at $21.89) and disposed of $93,486,391 worth of shares (4,271,124 units at $21.89), decreasing direct ownership by 0.00% to 33,653,755 units (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- President & Immunovant CEO Venker Eric exercised 200,000 shares at a strike of $3.85 and sold $4,170,000 worth of shares (200,000 units at $20.85) (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- CFO Pulik Richard covered exercise/tax liability with 1,235 shares, decreasing direct ownership by 0.32% to 388,273 units (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- President & Immunovant CEO Venker Eric covered exercise/tax liability with 7,051 shares, decreasing direct ownership by 0.47% to 1,497,908 units (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- Director Manchester Keith S sold $26,304,500 worth of shares (1,300,000 units at $20.23) (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- Director Gold Daniel Allen sold $26,304,500 worth of shares (1,300,000 units at $20.23) (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- Director by Deputization Qvt Financial Lp sold $26,304,500 worth of shares (1,300,000 units at $20.23) (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)
- Large owner Ramaswamy Vivek sold $37,939,112 worth of shares (1,854,603 units at $20.46), decreasing direct ownership by 5% to 33,653,756 units (SEC Form 4)4 - Roivant Sciences Ltd. (0001635088) (Issuer)